Egetis Therapeutics AB (publ) (STO:EGTX)

Egetis Therapeutics AB Revenue

Egetis Therapeutics AB had revenue of 17.40M SEK in the quarter ending June 30, 2026, with 20.00% growth. This brings the company's revenue in the last twelve months to 66.00M, up 39.24% year-over-year. In the year 2025, Egetis Therapeutics AB had annual revenue of 62.40M with 35.36% growth.

• Revenue (ttm): 66.00M
• Revenue Growth: +39.24%
• P/S Ratio: 55.58
• Revenue / Employee: 1.18M
• Employees: 56
• Market Cap: 3.67B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	62.40M	16.30M	35.36%
Dec 31, 2024	46.10M	-11.50M	-19.97%
Dec 31, 2023	57.60M	35.00M	154.87%
Dec 31, 2022	22.60M	-15.60M	-40.84%
Dec 31, 2021	38.20M	-2.46M	-6.05%
Dec 31, 2020	40.66M	-41.90M	-50.75%
Dec 31, 2019	82.56M	-	-

Data Source: Fiscal.ai Last updated: Aug 21, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error